NIPG Q2 2025 Earnings Massive EPS Miss and Steep Stock Decline Raise Red Flags Castle Biosciences Q1 2026 Earnings Narrowly Beats EPS Estimates but Stock Declines AIxCrypto Holdings Inc AIXC Q3 2023 Earnings Significant EPS Beat Despite Ongoing Challenges Processa Pharmaceuticals Inc PCSA Q4 2025 Earnings WiderThanExpected Loss as Clinical Pipeline Progresses ANTA Q1 2026 Earnings Significant EPS Miss Triggers Stock Decline AMKR Q1 2026 Earnings Strong EPS Beat Amid Mixed Signals Stock Slightly Lower